Psoriatic arthritis
Dementia risk lower in people treated with biologic DMARDs
Biologic disease-modifying antirheumatic drugs (DMARDs) may have neuroprotective effects according to exciting new meta-analysis in RMD Open. Conventional synthetic DMARDs did not show a similar outcome. Continue reading
Microneedles: a new technique to administer arthritis drugs?
People with arthritis may one day receive their medication via microneedles, a team explains in a leading journal. Continue reading
Ginger to treat autoimmune disease
The important role ginger can play in controlling inflammation for people living with autoimmune diseases is revealed in a new study in JCI Insight. The research looked at the impact of ginger supplements on people’s white blood cell function.
Biolubricants will be created to combat arthritis
A US team has been given a grant to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
Psoriasis drug risankizumab approved for Crohn’s disease in the UK
Health chiefs have given the green light to risankizumab for NHS patients with difficult-to-treat Crohn’s disease.
